Drug discovery in prostate cancer mouse models

Kenneth C. Valkenburg, Kenneth Pienta

Research output: Contribution to journalArticle

Abstract

Introduction: The mouse is an important, though imperfect, organism with which to model human disease and to discover and test novel drugs in a preclinical setting. Many experimental strategies have been used to discover new biological and molecular targets in the mouse, with the hopes of translating these discoveries into novel drugs to treat prostate cancer in humans. Modeling prostate cancer in the mouse, however, has been challenging, and often drugs that work in mice have failed in human trials.Areas covered: The authors discuss the similarities and differences between mice and men; the types of mouse models that exist to model prostate cancer; practical questions one must ask when using a mouse as a model; and potential reasons that drugs do not often translate to humans. They also discuss the current value in using mouse models for drug discovery to treat prostate cancer and what needs are still unmet in field.Expert opinion: With proper planning and following practical guidelines by the researcher, the mouse is a powerful experimental tool. The field lacks genetically engineered metastatic models, and xenograft models do not allow for the study of the immune system during the metastatic process. There remain several important limitations to discovering and testing novel drugs in mice for eventual human use, but these can often be overcome. Overall, mouse modeling is an essential part of prostate cancer research and drug discovery. Emerging technologies and better and ever-increasing forms of communication are moving the field in a hopeful direction.

Original languageEnglish (US)
Pages (from-to)1011-1024
Number of pages14
JournalExpert Opinion on Drug Discovery
Volume10
Issue number9
DOIs
StatePublished - Sep 2 2015

Fingerprint

Drug Discovery
Prostatic Neoplasms
Pharmaceutical Preparations
Expert Testimony
Heterografts
Immune System
Communication
Research Personnel
Guidelines
Technology

Keywords

  • drug discovery
  • model organism
  • mouse models
  • prostate cancer

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Drug discovery in prostate cancer mouse models. / Valkenburg, Kenneth C.; Pienta, Kenneth.

In: Expert Opinion on Drug Discovery, Vol. 10, No. 9, 02.09.2015, p. 1011-1024.

Research output: Contribution to journalArticle

Valkenburg, Kenneth C. ; Pienta, Kenneth. / Drug discovery in prostate cancer mouse models. In: Expert Opinion on Drug Discovery. 2015 ; Vol. 10, No. 9. pp. 1011-1024.
@article{b2a275dab5584b27888f80c3aadccafc,
title = "Drug discovery in prostate cancer mouse models",
abstract = "Introduction: The mouse is an important, though imperfect, organism with which to model human disease and to discover and test novel drugs in a preclinical setting. Many experimental strategies have been used to discover new biological and molecular targets in the mouse, with the hopes of translating these discoveries into novel drugs to treat prostate cancer in humans. Modeling prostate cancer in the mouse, however, has been challenging, and often drugs that work in mice have failed in human trials.Areas covered: The authors discuss the similarities and differences between mice and men; the types of mouse models that exist to model prostate cancer; practical questions one must ask when using a mouse as a model; and potential reasons that drugs do not often translate to humans. They also discuss the current value in using mouse models for drug discovery to treat prostate cancer and what needs are still unmet in field.Expert opinion: With proper planning and following practical guidelines by the researcher, the mouse is a powerful experimental tool. The field lacks genetically engineered metastatic models, and xenograft models do not allow for the study of the immune system during the metastatic process. There remain several important limitations to discovering and testing novel drugs in mice for eventual human use, but these can often be overcome. Overall, mouse modeling is an essential part of prostate cancer research and drug discovery. Emerging technologies and better and ever-increasing forms of communication are moving the field in a hopeful direction.",
keywords = "drug discovery, model organism, mouse models, prostate cancer",
author = "Valkenburg, {Kenneth C.} and Kenneth Pienta",
year = "2015",
month = "9",
day = "2",
doi = "10.1517/17460441.2015.1052790",
language = "English (US)",
volume = "10",
pages = "1011--1024",
journal = "Expert Opinion on Drug Discovery",
issn = "1746-0441",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Drug discovery in prostate cancer mouse models

AU - Valkenburg, Kenneth C.

AU - Pienta, Kenneth

PY - 2015/9/2

Y1 - 2015/9/2

N2 - Introduction: The mouse is an important, though imperfect, organism with which to model human disease and to discover and test novel drugs in a preclinical setting. Many experimental strategies have been used to discover new biological and molecular targets in the mouse, with the hopes of translating these discoveries into novel drugs to treat prostate cancer in humans. Modeling prostate cancer in the mouse, however, has been challenging, and often drugs that work in mice have failed in human trials.Areas covered: The authors discuss the similarities and differences between mice and men; the types of mouse models that exist to model prostate cancer; practical questions one must ask when using a mouse as a model; and potential reasons that drugs do not often translate to humans. They also discuss the current value in using mouse models for drug discovery to treat prostate cancer and what needs are still unmet in field.Expert opinion: With proper planning and following practical guidelines by the researcher, the mouse is a powerful experimental tool. The field lacks genetically engineered metastatic models, and xenograft models do not allow for the study of the immune system during the metastatic process. There remain several important limitations to discovering and testing novel drugs in mice for eventual human use, but these can often be overcome. Overall, mouse modeling is an essential part of prostate cancer research and drug discovery. Emerging technologies and better and ever-increasing forms of communication are moving the field in a hopeful direction.

AB - Introduction: The mouse is an important, though imperfect, organism with which to model human disease and to discover and test novel drugs in a preclinical setting. Many experimental strategies have been used to discover new biological and molecular targets in the mouse, with the hopes of translating these discoveries into novel drugs to treat prostate cancer in humans. Modeling prostate cancer in the mouse, however, has been challenging, and often drugs that work in mice have failed in human trials.Areas covered: The authors discuss the similarities and differences between mice and men; the types of mouse models that exist to model prostate cancer; practical questions one must ask when using a mouse as a model; and potential reasons that drugs do not often translate to humans. They also discuss the current value in using mouse models for drug discovery to treat prostate cancer and what needs are still unmet in field.Expert opinion: With proper planning and following practical guidelines by the researcher, the mouse is a powerful experimental tool. The field lacks genetically engineered metastatic models, and xenograft models do not allow for the study of the immune system during the metastatic process. There remain several important limitations to discovering and testing novel drugs in mice for eventual human use, but these can often be overcome. Overall, mouse modeling is an essential part of prostate cancer research and drug discovery. Emerging technologies and better and ever-increasing forms of communication are moving the field in a hopeful direction.

KW - drug discovery

KW - model organism

KW - mouse models

KW - prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=84938944790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938944790&partnerID=8YFLogxK

U2 - 10.1517/17460441.2015.1052790

DO - 10.1517/17460441.2015.1052790

M3 - Article

C2 - 26027638

AN - SCOPUS:84938944790

VL - 10

SP - 1011

EP - 1024

JO - Expert Opinion on Drug Discovery

JF - Expert Opinion on Drug Discovery

SN - 1746-0441

IS - 9

ER -